Spruce Biosciences

Completing steps towards success checkmark on cubes symbolizing progress
Biotech

Spruce’s successful FDA talks plant seeds for Q4 filing

Spruce took another step toward filing for FDA approval, ticking off some of the manufacturing tasks needed to submit the long-awaited application.
Nick Paul Taylor Aug 24, 2026 9:57am
Graphic of a broom sweeping up employees

Spruce halves head count in push to get ex-BioMarin drug to FDA

Apr 28, 2025 8:15am
Graphic image of a pen signing a signature while two strangelooking business people cheer

Spruce inks deal for BioMarin asset, plans 2026 approval filing

Apr 15, 2025 10:29am
chop down cut tree chainsaw ax

Spruce drops only drug after 2nd hyperplasia phase 2 fail

Dec 11, 2024 5:00am
chop down cut tree chainsaw ax

Spruce lays off 5th of staff in wake of phase 2 hyperplasia fail

Mar 14, 2024 8:27am
Parachute

Pfizer taps former CVS exec Denton for CFO role—Chutes & Ladders

Apr 15, 2022 9:30am